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Abstract 34 
Objective: To investigate the prevalence of miscarriage in women with endometriosis (WwE) 35 
compared to disease-free control women (CW). 36 
Design: Cross-sectional analysis nested in retrospective observational study (n = 940). 37 
Setting: Women recruited in 9 Swiss, German and Austrian hospitals and associated private 38 
practices. 39 
Patient(s): Previously pregnant women (N= 268) within reproductive age in matched pairs. 40 
Intervention: Retrospective analysis of surgical reports and self-administered 41 
questionnaires. 42 
Main Outcome Measure(s): Rate of miscarriage, subanalysis for fertility status (≤12 vs. >12 43 
months time to conception), endometriosis stages (rASRM I/II vs. III/IV) and phenotypic 44 
localisations (superficial peritoneal SUP, ovarian OMA and deep infiltrating DIE 45 
endometriosis). 46 
Result(s): The miscarriage rate is higher in WwE 35.8% (29.6-42.0) compared to CW 22.0% 47 
(16.7–27.0); adjusted incidence risk ratio (IRR) of 1.97 (95% CI 1.41–2.75); p <0.001.  48 
This remained significant in subfertile WwE 50.0% (40.7–59.4) vs. CW 25.8% (8.5–41.2); p = 49 
0.017, but not in fertile WwE 24.5% (16.3–31.6) vs. CW 21.5% (15.9–26.8); p = 0.548. The 50 
miscarriage rate was higher in women with milder forms rASRM I/II 42.1% (32.6–51.4) vs. 51 
rASRM III/IV 30.8% (22.6–38.7), compared to 22.0% (16.7–27.0) in CW; p <0.001, and in 52 
women with SUP 42.0% (32.0–53.9) compared OMA 28.6% (17.7–38.7) and DIE 33.9% 53 
(21.2–46.0) compared to CW 22.0% (16.7–27.0); p = 0.005.  54 
Conclusion(s): Mild endometriosis, as in superficial lesions is related to a great extent of 55 
inflammatory disorder, possibly leading to defective folliculogenesis, fertilization and/or 56 
implantation presenting as increased risk of miscarriage.   57 
Trial registration number: NCT 02511626. 58 
 59 
Key Words: endometriosis, miscarriage, infertility, pregnancy outcome, superficial peritoneal 60 
endometriosis  61 
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Introduction 62 
Endometriosis is a chronic and often progressive disease, which is defined by endometriotic 63 
tissue outside the uterine cavity that is sensitive to cyclic steroid hormone regulation (1-3). 64 
With a prevalence of 6 - 10% of the female population, it is one of the most important benign 65 
gynecological diseases in women in their reproductive age (4). Endometriosis is associated 66 
with dysmenorrhea, dyspareunia, or chronic pelvic pain. Endometriosis is known to reduce 67 
female fertility (4-6) and has an impact on the obstetric outcome of affected women (7-10).  68 
In WwE multifactorial reasons result in a reduction in fertility: Reduced tubal motility and 69 
passage (11,12), inhibiting inflammatory factors deriving from the peritoneal fluid (13), and a 70 
diminished quality of the oocytes affect the chances of a successful implantation after natural 71 
conception as well as after assisted reproductive technology (ART) (14-17). However, not all 72 
the underlying mechanisms are yet fully understood. Over the last few years, the 73 
improvements in pharmacological, surgical, and ART treatment led to an increasing number 74 
of pregnancies in WwE (18). The success of pregnancy depends on the placentation and the 75 
endometrial function later in pregnancy (19,20). Abnormal local estrogen production and an 76 
altered endometrial response to progesterone (progesterone resistance) result in a changed 77 
microenvironment. This coats the embryo in early pregnancy (21,22) possibly affecting the 78 
“quality of implantation”. Miscarriage is the most common complication during the first 79 
trimester with an incidence rate of 30 - 50% in the general population, depending primarly on 80 
the age of the women (23,24). There is no conclusive answer to the question of whether or 81 
not miscarriage rates are increased in WwE: Earlier clinical studies investigated primarily the 82 
effect of surgical treatment (ablation of endometriotic lesions) on the prevalence of 83 
pregnancy complications; these studies were not adjusted for age (25-27). Some newer 84 
studies considering age as a risk factor and showed an association of endometriosis with 85 
previous pregnancy losses (8,9,28), but others did not (7, 30-32). A large Canadian cohort 86 
study over 12 years with registry data from 784 WwE and 30,284 CW reported a significantly 87 
higher rate of miscarriages in WwE (odds ratio 1.89, 95% CI 1.23 – 2.93); however, the 88 
diagnostic quality of endometriosis was limited (8). The most recent study on previously 89 
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pregnant women with and without endometriosis was conducted at a specialized referral 90 
center. It found a higher miscarriage rate in endometriosis-affected women 29.1% (23.9 – 91 
34.3) compared to control women 19.4% (16.1 – 22.7), p = 0.001 (7). Because of the high 92 
number of women with progressive disease (several surgeries before inclusion in the study) 93 
and severe endometriosis lesions, women with mild or asymptomatic disease were rather 94 
underrepresented in this collective.  95 
Our primary aim was to evaluate and compare miscarriage rates in a population of women 96 
with surgically confirmed endometriosis and a broad variety of clinical manifestations; in 97 
order to reflect the average female population affected by endometriosis. To improve our 98 
understanding of the association between endometriosis and miscarriage, we included in the 99 
analysis the phenotypical disease localization and the fertility status.   100 
 101 
Methods  102 
This is a cross-sectional analysis about the prevalence of miscarriages nested in a 103 
retrospective observational study (n = 940) on the quality of life in WwE.  104 
 105 
Questionnaire 106 
We designed a questionnaire focusing on the women’s health and obstetric history. We 107 
collected sociodemographic data and asked the women whether or not they had difficulties 108 
conceiving and for how long they tried to become pregnant.  109 
 110 
Recruitment 111 
Women from the ages of 18 to 45 were recruited between December 2010 and December 112 
2015 at participating hospitals or associated private practices. Participants were recruited at 113 
university hospitals in Switzerland, Germany and Austria (University Hospital Zurich, Charité 114 
– Medical University Berlin, University Hospital of Graz, and RWTH Aachen University), 115 
cantonal hospitals in Switzerland (Schaffhausen, Winterthur, St. Gallen, Solothurn), the 116 
Stadtspital Triemli Zurich and in associated private medical practices. Inclusion criteria were 117 
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defined as not being pregnant and being able to complete the questionnaire (without 118 
linguistic, mental or psychological impairment). Patients having undergone surgery for the 119 
diagnosis of endometriosis and fulfilling inclusion criteria were invited to participate and 120 
asked for informed consent. CW without clinical suspicion of endometriosis (no severe 121 
dysmenorrhoea, no heavy cyclic abdominopelvic pain) fulfilling the inclusion criteria were 122 
recruited during annual check-ups. In total 647 women affected by endometriosis and 666 123 
CW were invited to participate. Of those invited, written consent was received from 505 WwE 124 
(78.0%), and 435 CW (65.3%) respectively. 125 
 126 
Surgical reports 127 
Surgical reports for each surgical intervention were obtained from the patients’ clinics. 128 
From 468 out of 505 WwE (92.7%), we obtained surgical reports with sufficient details to do 129 
a correct staging and grading of the lesions. In 438 of 468 WwE (93.6%), the diagnosis was 130 
confirmed histologically after surgical resection; 30 of 468 WwE (6.4%) were diagnosed 131 
surgically, primarily after laser evaporation of light lesions. To avoid bias, all surgical and 132 
histological records were reviewed by two blinded investigators. 133 
The documents reviewed contained the total number of endometriosis-associated surgeries, 134 
the histological confirmation of endometriosis, a description of the localization and size of 135 
endometriosis lesions and the dimensions of adhesions. The revised classification of the 136 
American Society for Reproductive Medicine (rASRM) (33) was used to categorize the 137 
endometriosis into the four stages. This staging was applied, as it was initially developed to 138 
define chances for pregnancy (34). Additionally, the lesions were classified into three 139 
phenotypes: superficial peritoneal endometriosis (SUP), ovarian endometriosis (OMA), and 140 
deep infiltrating endometriosis (DIE), as previously described by other investigators (35,36). 141 
DIE lesions were classified as ≥ 5mm deep invasive endometriotic lesions. (2,37).  As those 142 
three different phenotypes often present together, patients were classified according to their 143 
most severe lesion, used for grading as follows:  DIE >OMA >SUP (35,38).  144 
 145 
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Statistical analysis 146 
We analyzed responses regarding the number of previous miscarriages, the number of 147 
pregnancies conducted beyond the 24th gestational week, and the number of deliveries.  148 
All data were stored in a computerized database. Statistical analysis was performed using 149 
STATA statistical software Version 14 (Stata Corporation, College Station, TX, USA). Data 150 
were presented as absolute numbers (n) and as percentages, with 95% confidence intervals 151 
(95% CIs). Differences among groups were analyzed by chi-square tests for categorical data; 152 
the Student’s t-test was used for quantitative data.  Miscarriage rates were defined as the 153 
rate of previous failures relative to the total number of previous pregnancies. We calculated 154 
the miscarriage rate for the rASRM stages and the most severe phenotypic endometriosis 155 
localization in fertile and subfertile subpopulations. Adjustments were made for known risk 156 
variables: age (≤29, 30-35, ≥35 years), BMI (≤19, 20-24, 25-29 and ≥30 kg/m2) and smoking 157 
(never a smoker, previous smoker, and current smoker) as categorical variables. Due to 158 
missing values (18/268), multiple imputations were made for “smoking”. “Previous 159 
miscarriage” is not independent in our population, because women can have more than one 160 
miscarriage. Therefore, we applied a hierarchical mixed effect model (Poisson regression) to 161 
account for the matched pairs (level I) and for pregnancies within the same woman (level II). 162 
We calculated the rate of miscarriages/pregnancies within our population (39). The model 163 
was chosen because each event has a defined onset (pregnancy) with a defined endpoint 164 
(miscarriage or delivery). The level of significance was set at p <0.05 and p <0.001 for 165 
multiple testing.  166 
 167 
Ethics 168 
The regional ethical review committees as well as the ethic boards of the participating 169 
hospitals in Switzerland, Germany, and Austria approved the study. All women provided 170 
signed informed consent for study participation as well as verification of endometriosis 171 
diagnosis through their medical charts. The trial was conducted in accordance with the 172 
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Declaration of Helsinki. It was registered at clinicaltrials.gov, under the reference number 173 
NCT 02511626.   174 
 175 
Results  176 
Study population  177 
For this analysis, woman with previous pregnancies were selected as shown in Figure I. In 178 
the final analysis we included 143 WwE matched for age with 143 CW, out of 203 (total n = 179 
286). Most WwE were born within 12 months of their matching CW (120 pairs) the remaining 180 
were born at most 24 months apart (23 pairs). Of the 286 women, a total of 508 previous 181 
pregnancies was analyzed.  182 
Patient characteristics of 143 WwE and 143 CW were analyzed (Table 1). There were no 183 
significant differences in the characteristics of the two groups beside the lower parity in WwE: 184 
a total number of 152 children were delivered by WwE, compared to 204 children born of 185 
CW; 32 WwE (22.4%) and 13 CW (9.1%) were nulliparous; p = 0.001. 186 
Among WwE, 33 were staged with rASRM I (23.1%), 26 with rASRM II (18.2%), 42 with 187 
rASRM III (29.4%) and 42 with rASRM IV (29.4%). The phenotypically most severe 188 
endometriosis lesion was a SUP in 48 women (33.6%), an OMA in 47 women (32.8%), and a 189 
DIE in 48 women (33.6%). Of the 48 women with DIE, 33 had cul de sac lesions, 11 had an 190 
invasive lesion on the sacrouterine ligament and 4 had invasive peritoneal lesions of other 191 
localisations. The mean number of surgical interventions related to endometriosis per WwE 192 
was 1.87 (range 1-9).  193 
 194 
Miscarriages 195 
In our analysis, 240 pregnancies in WwE and 268 pregnancies in CW were included (Figure 196 
I). The total number of miscarriages per woman was similar in both groups: 36 WwE and 30 197 
CW had one previous miscarriage; 13 WwE and eight CW had two previous miscarriages. 198 
Recurrent miscarriages, with three or more miscarriages (according to the ESHRE 199 
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classification, 40), occurred in a total of 11/286 (3.9%) women, 7/143 (4.9%) WwE, and 200 
4/143 (2.8%) CW, p = 0.874.  201 
Table 2 shows miscarriage rates in relation to fertility, localization of the most severe lesions, 202 
and disease stage. Generally, the miscarriage rate was significantly higher in WwE 203 
compared to CW (Table 2). This difference remained significant for subfertile women 204 
independent of previous ART, but the miscarriage rate for fertile WwE did not differ from the 205 
miscarriage rate for fertile CW.  206 
Mild and severe endometriosis were both associated with a higher prevalence of 207 
miscarriages compared to CW. This relationship was stronger in mild endometriosis (rASRM 208 
I/II) than in severe endometriosis (rASRM III/IV), compared to CW. The miscarriage rate was 209 
highest in women diagnosed with SUP, followed by women diagnosed with DIE, and then by 210 
women diagnosed with OMA. 211 
Our regression model confirmed a higher rate of previous miscarriages for WwE compared to 212 
CW (Table 3), also after adjustment for risk factors for miscarriage such as age, BMI, 213 
subfertility, and smoking habit. The adjusted IRR for previous miscarriages was significantly 214 
increased in subfertile but not in fertile WwE. The adjusted IRR for previous miscarriages 215 
was significantly higher in cases of mild and of superficial peritoneal endometriosis compared 216 
to CW. 217 
 218 
Discussion  219 
This study shows a higher rate of previous miscarriages in WwE, especially in women with 220 
minimal or mild disease, compared to CW in the adjusted analysis. We show that primarly 221 
women with milder forms of endometriosis as well as subfertile woman are affected by 222 
miscarriages. This allows a clearer picture among different types of endometriosis and 223 
indicates that the diagnosis of endometriosis should not generally be associated with a 224 
higher risk for miscarriage. It also means that young women with early stages of 225 
endometriosis, a good ovarian reserve and tube motility should be reassured and 226 
encouraged to try for a spontaneous conception.  227 
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 228 
A strength of this study is the inclusion of women recruited in secondary, and tertiary centers 229 
as well as in private practices: this distribution offers a considerably representative sample of 230 
the female population treated for endometriosis. While many women diagnosed with 231 
endometriosis suffer from severe pain symptoms and a decreased quality of life, others 232 
experience fewer pain symptoms and a quality of life similar to that of the general population 233 
(41).  WwE treated in secondary and tertiary centers seem to differ in disease symptoms and 234 
associated quality of life (42) from women treated in primary care centers. As most studies 235 
focus on the presence of disease symptoms, WwE with few symptoms and satisfactory 236 
quality of life are underrepresented in most scientific studies conducted at universitary care 237 
centers. Our recruitment strategy was applied to overcome this selection bias and reflect the 238 
average female population affected and treated by endometriosis. 239 
 240 
Because of the heterogeneity of endometriosis lesions, classification systems often show 241 
only weak associations with disease symptoms (41). Another strength of this study, is the 242 
application of both the well-known classification system of the American Society for 243 
Reproductive Medicine (rASRM; 33) and the surgical phenotypic classification of 244 
endometriosis adopting the description of the most severe endometriosis lesion (SUP <OMA, 245 
<DIE) (36). It has been shown that phenotypic classification corresponds better to the 246 
obstetric outcome than the rASRM classification (42,43). The even distribution of SUP, OMA, 247 
and DIE as the most severe localization of the endometriosis disease within our study 248 
population allows for a reliable evaluation of the role of different lesion locations in the risk for 249 
miscarriage.  250 
Furthermore the analysis based on the mixed-effects Poisson regression model accounting 251 
for the non-independence of pregnancies within the same women delivers very reliable 252 
results. Recall bias was minimized through the selection of women with previous 253 
pregnancies for evaluation within an observational study on quality of life in WwE, e.g. the 254 
women were not aware of this particular investigation’s hypothesis. The sample size was 255 
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large and the age ranges particularly narrow: matching in the present study provided a 256 
control sample out of the same population. This is particularly important because age is the 257 
most important risk factor for miscarriages. 258 
The following limitations have to be taken into consideration: data analysis was based on 259 
questionnaire information; beside reporting on endometriosis related surgery, no other 260 
medical records were reviewed, diagnosis of endometriosis was based on surgical and 261 
histological reports. Laparoscopy with or without histological verification is widely used to 262 
diagnose and rule out the presence of endometriosis. However, the correct diagnosis of 263 
endometriosis depends highly on the abilities of the surgeon performing the laparoscopy. 264 
Hidden endometriosis lesions retroperitoneally or vaginally can be easily missed, especially if 265 
the patient has not been thoroughly examined preoperatively (44)In the past surgical 266 
judgment was proven to be equivalent to histological diagnosis (45). Surgical and histological 267 
reports did not allow inclusion of possible adenomyotic lesions, because correct diagnosis 268 
would need specific ultrasound assessment of the uterine morphology (46). Uterine 269 
adenomyosis is known to frequently coexist with endometriosis (15) and is associated with 270 
an increased risk for miscarriages (47). 271 
Acquired information about infertility and reasons for subfertility and ART treatment is based 272 
on the patients’ answers. Pregnancy, the loss of a pregnancy and deliveries are life events, 273 
so recall is most likely correct and, if biased, then for WwE and CW in the same manner. In 274 
women affected with endometriosis, sensitivity to possible infertility might be higher, as it is 275 
known and often communicated, that endometriosis might affect fertility. This could lead to 276 
an information bias and could affect the detection of a pregnancy different from that of CW. 277 
As a further limitation, asymptomatic endometriosis in the control group cannot be excluded, 278 
since not all of the CW had surgical treatment and were included into the study after the 279 
exclusion of symptoms suspicious for endometriosis. This recruitment was the best possible, 280 
since recruitment of women undergoing laparoscopy for gynecological non-endometriosis 281 
reasons such as e.g. tubal ligation or removal of benign ovarian cysts have an affected 282 
fertility, so they impose a selection bias. However, missed diagnosis of endometriosis in the 283 
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control group would lead to an overestimation of the described effect. The recruitment in 284 
different centres reduces selection bias in regard to similarity with the general population, 285 
both in WwE and CW. Because of the number of missing answers for thyroid disease, and 286 
immunological disorders, we could not include these specific risk factors into our mixed-effect 287 
regression model.   288 
 289 
Our results are in agreement with large registry-based studies (8,48), showing a higher 290 
prevalence of miscarriages in women diagnosed with endometriosis than in CW. Studies 291 
showing no difference in miscarriage rates between women with and without endometriosis 292 
focus either on ART-treated women (31,32) or women with surgically treated septate uteri 293 
(30). Both of these conditions might imply a higher impact on miscarriage rates than the 294 
endometriosis itself. The following mechanisms support our results indicating an association 295 
between endometriosis and miscarriages: pathophysiologically, an impaired folliculogenesis 296 
and an insufficient endometrial function in WwE have been postulated. The eutopic 297 
endometrium may not function normally in WwE: inflammation processes lead to an 298 
increased release of reactive oxygen species (ROS) and an increased expression of 299 
enzymes (17). These enzymes induce an accumulation of free radicals in cells near and in 300 
the endometrium, which possibly affect implantation (17). Additionally, ROS affect the mitotic 301 
spindle as well as the separation of chromosomes and consequently delay completion of 302 
meiosis I during fertilization (49,50); this could provide an explanation for a lower oocyte 303 
quality in endometriosis, as shown in animal studies (51).  304 
Physiologically, progesterone induces the decidualization of stromal cells of the endometrium 305 
to become receptive for the embryo (52). As a consequence of progesterone resistance in 306 
endometriosis, this process may become dysregulated and lead to suboptimal implantation  307 
(6). Endometriosis affected tissue shows different pathological features, for example delayed 308 
maturation, altered glycosylation and molecular abnormalities such as alterations in local 309 
steroid biosynthesis, cell growth, apoptosis, immune-cell function, angiogenesis, cell 310 
adhesion, and cytokine production, all of which might reduce chances of a successful 311 
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pregnancy outcome (14, 53, 54, 55). In the literature the use of anti-inflammatory hormonal 312 
(56,57) and non-hormonal (58) treatments for pain symptoms have been examined. It is 313 
recommended that they be investigated further for their potential to improve implantation and 314 
reduce miscarriages.  315 
In addition, in endometriosis inadequate uterine contractions occur throughout the menstrual 316 
cycle; the frequency, amplitude and basal pressure have been shown to be higher and 317 
possibly favor miscarriages (17). 318 
 319 
The higher miscarriage rate in lower stages of endometriosis detected in our study is in line 320 
with findings from other authors: the recent analysis by Santulli et al. (9) showed a higher 321 
rate of miscarriages for all phenotypes of endometriosis e.g. SUP, OMA and, DIE compared 322 
to CW. As in our study, the highest miscarriage rate was reported for “mildest” SUP lesions 323 
(n = 33/87; 37.9%) vs. OMA lesions (n = 28/104; 26.9%) vs. DIE lesions (n = 78/287; 27.2%). 324 
In both studies, the higher rate of previous miscarriages in women with SUP could be the 325 
result of a higher pregnancy rate among these women: women with more severe lesions 326 
such as OMA or DIE are more likely to have a lower reproductive performance (59,60) or 327 
poor motility of the fallopian tubes (11), with consecutively lower spontaneous over all 328 
pregnancy rates.  329 
In contrast, a meta-analysis of reproductive outcomes by Barbosa (60) did not show a 330 
significant difference in miscarriages between mild and severe endometriosis-affected 331 
women. Only 21 out of 92 studies included in this meta-analysis reported rASRM staging of 332 
endometriosis, so evidence in relation to ASRM staging was considered low.  333 
Pathophysiological mechanisms might explain the finding of increased miscarriage rates in 334 
WwE but also especially in women with mild endometriosis: early stages of the disease with 335 
more active lesions are known to lead to a more inflammatory milieu (61,62), compared to 336 
the more scarring lesions of higher disease stages (63). Fresh endometriosis lesions seem to 337 
be associated with an inflammatory response represented by overproduction of 338 
prostaglandins, metalloproteinases, cytokines, and chemokines (3). The resulting 339 
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inflammatory process impairs ovarian, peritoneal, tubal, and endometrial function, and may 340 
lead to defective folliculogenesis by altered follicular milieu because of increased rates of 341 
granulosa cell apoptosis (64) as well as increased concentrations of follicular fluid natural 342 
killer cells and lymphocytes (65), fertilization, and/or implantation (5). However it has been 343 
shown very recently, that the rate of aneuploidy rate in patients affected by endometriosis is 344 
not increased (66). This could lead us to the speculation that the impact of mild 345 
endometriosis on fertility might be due to non-genetic rather metabolic intracellular 346 
processes; so either insufficient oocyte maturation with retardation of the embryo before 347 
reaching blastocyst stage or on insufficient embryonal development either because of altered 348 
endometrial receptivity (67)  and therefore reduced  „supply“ or an impariment of intracellular 349 
metabolism probably also in trophoblast development.  350 
There is an association of miscarriages in subfertile women with and without endometriosis. 351 
Additionally, subfertile women often require ART, an intervention possibly associated with 352 
complications later in pregnancy such as e.g. preterm birth and low birth weight (68). ART 353 
itself does not pose a risk for miscarriages, but the underlying specific reproductive disorders 354 
and the increased age, both affecting oocyte quality are of very high importance when 355 
assessing miscarriage risk (69) in these women.  356 
Based on this knowledge, our results of highest IRR for subfertile women with endometriosis 357 
are not surprising. In contrast our finding that there is no difference in the prevalence of 358 
miscarriages between fertile WwE and fertile CW is very important for counseling.  359 
Our findings are in contrast to the above-mentioned recent study (9), where the risk for 360 
miscarriages in fertile women with endometriosis (67/341; 19.6%) was significantly higher 361 
than in control women (72/583; 12.3%). However, the miscarriage rates in both of these 362 
groups were lower compared to our and other studies (70). The reason for the differences in 363 
these results might be the older age of women, e.g. the higher risk for miscarriage at the time 364 
of inclusion into our study.  365 
In conclusion, our study found that miscarriage rates are higher in endometriosis-affected 366 
women, especially in women with mild lesions and those suffering from infertility. Further 367 
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14 
studies, especially prospective controlled studies, are necessary to confirm our findings. A 368 
retrospective study such as this, with the attendant limitations of study design, cannot 369 
definitely prove the hypothesis. Analyzing underlying pathophysiological mechanisms such 370 
as the folliculogenesis and the endometrial function may help to better understand the 371 
etiology of miscarriages and develop effective treatments to improve chances for successful 372 
pregnancy in women with endometriosis.  373 
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Figure legends 382 
Figure  1 383 
Patient inclusion flow-chart 384 
WwE: Women with endometriosis, CW: Control women 385 
Table 1 386 
Patient characteristics  387 
WwE: Women with endometriosis, CW: Control women 388 
Data reported as mean ± standard deviation or number (%) 389 
a: chi-square test; b: t-test 390 
Table 2 391 
N= number of miscarriages/ pregnancies 392 
WwE: Women with endometriosis, CW: Control women 393 
a: chi-square test 394 
Rates of previous miscarriages according infertility and rates of previous miscarriages according 395 
surgery   396 
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rASRM: revised American Society of Reproductive Medicine classification (ASRM 1997) 397 
Surgical phenotypical classification (Chapron et al. 2010) 398 
SUP: superficial endometriosis;  OMA: ovarian endometrioma; DIE: deep infiltrating endometriosis 399 
Table 3 400 
Incidence rate ratio (IRR) of previous miscarriages from the mixed-effects Poisson regression analysis 401 
WwE: Women with endometriosis, CW: Control women 402 
a: adjusted for age, BMI, smoking* habits and subfertility 403 
*: imputation for smoking because of missing answers 404 
rASRM: revised American Society of Reproductive Medicine classification (ASRM 1997) 405 
Surgical phenotypical classification (Chapron et al. 2010) 406 
SUP: superficial endometriosis;  OMA: ovarian endometrioma; DIE: deep infiltrating endometriosis 407 
 408 
 409 
 410 
 411 
 412 
 413 
 414 
 415 
 416 
 417 
 418 
 419 
 420 
 421 
 422 
Table 1     Women with endometriosis Control women         423 
     (WwE)   (CW)                           424 
.     N = 143   N = 143                   p- value 425 
Age (years)    37.34 ± 4.83  37.45 ± 4.78 0.898a 426 
BMI (kg/m2)    23.10 ± 4.24  23.47 ± 3.77 0.584a 427 
 428 
Smoking habits (n, %) 429 
Never smoked    66 (46.1%)  77 (53.8%)          0.301a 430 
Previous smoker    46 (32.2%)  37 (25.9%) 431 
Current smoker    23 (16.1%)  18 (12.6%) 432 
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Not available    8 (5.6%)   11 (7.7%) 433 
 434 
Gravidity (n, %) 435 
 1    83 (58%)   64 (44.7%) 0.071a 436 
 2    37 (29.5%)  52 (36.4%) 437 
 ≥3    23 (16.1%)  27 (23.9%) 438 
Parity (n, %) 439 
0    32 (22.4%)  13 (9.1%)         0.001a 440 
1    75 (52.4%)  67 (46.8%) 441 
2    31 (21.7%)  52 (36.4%) 442 
≥ 3    5 (3.5%)   11 (7.7%) 443 
 444 
Immunological disease (n,%)   14 (9.8%)  7 (4.9%)  0.890b 445 
Thyroid disease (n, %)   22 (15.4%)  19 (13.3%) 0.377b 446 
 447 
 448 
 449 
 450 
Table 2   451 
.  Endometriosis women (WwE) (total N= 240)  Control women (CW) (total N= 268) 452 
N Rate % (95% CI)     N Rate % (95% CI)   p- vala 453 
Total  86/240 35.8 (29.6 – 42.0)    59/268 22.0 (16.7 – 27.0)  <0.001 454 
Fertile women 32/132 24.5 (16.3 – 31.6)    51/237 21.5 (15.9 – 26.8)  0.548 455 
Subfertile women  54/108 50.0 (40.7 – 59.4)    8/31 25.8 (8.5 - 41.2)  0.017 456 
Previous ART 11/20 55.0 (36.5 – 76.8)    1/19 5.3 (0.1 – 15.3)  <0.001 457 
 458 
SUP   OMA   DIE   Controls   459 
N Rate % (95% CI) N Rate % (95% CI) N Rate % (95% CI) N Rate % (95% CI) p- vala460 
  461 
34/79 43.0 (32.0 – 53.9) 22/77 28.6 (17.7 – 38.7) 20/59 33.9 21.2 – 46.0) 59/268  22.0 (16.7 – 27.0) 0.005 462 
rASRM I/II  rASRM III/IV     Controls    463 
N Rate % (95% CI) N Rate % (95% CI)    N Rate % (95% CI) p- vala 464 
45/107 42.1 (32.6 – 51.4) 41/133 30.8 (22.6 – 38.7)    59/268  22.0 (16.7 – 27.0) <0.001 465 
 466 
 467 
Table 3  468 
.   Unadjusted IRR (95% CI) p-value  Adjusteda IRR (95% CI) p-value 469 
CW   Ref     Ref 470 
All WwE   1.62 (1.17 – 2.27)  0.004  1.97 (1.41 – 2.75)   <0.001 471 
 472 
Subfertile CW  Ref     Ref 473 
Subfertile WwE   1.94 (0.92 – 4.07)    0.081  2.41 (1.01 – 5.78)  0.048 474 
 475 
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Fertile CW  Ref     Ref 476 
Fertile WwE  1.13 (0.72 – 1.75)   0.597  1.11 (0.7 – 7.76)    0.657 477 
   478 
 479 
CW    Ref     Ref 480 
WwE with rASRM lesion I/II  1.91 (1.29 – 2.82)    0.001  1.57 (1.00 - 2.44)  0.046 481 
WwE with rASRM lesion III/IV 1.40 (0.94 – 2.08)    0.098  1.19 (0.76 - 1.85)  0.446 482 
WwE with SUP lesion 1.98 (1.33 – 2.95)    0.001  1.67 (1.07 - 2.61)  0.024  483 
WwE with OMA lesion 1.32 (0.81 – 2.14)    0.256  1.11 (0.65 - 1.88)  0.703 484 
WwE with DIE lesion 1.49 (0.91 – 2.43)    0.110  1.19 (0.70 - 2.61)  0.515 485 
 486 
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